Literature DB >> 32082878

Neutrophil-to-lymphocyte ratio for early renal failure under extracorporeal membrane oxygenation support for postcardiotomy shock.

Murat Sargın1, Müge Taşdemir Mete1, Sevinç Bayer Erdoğan1, Hüseyin Kuplay1, Murat Baştopçu1, Fatih Bayraktar1, Murat Acarel2, Serap Aykut Aka1.   

Abstract

BACKGROUND: This study aims to investigate the relationship between the neutrophil-to-lymphocyte ratio and renal injury in patients under extracorporeal membrane oxygenation support for postcardiotomy shock.
METHODS: Between January 2007 and July 2018, a total of 119 patients (38 males, 81 females; mean age 54.4±13.0 years; range, 24 to 74 years) who received extracorporeal membrane oxygenation support for postcardiotomy shock and survived at least 48 hours in our center were retrospectively analyzed. Pre- and postoperative neutrophil-to-lymphocyte ratios, demographic characteristics, renal function parameters, and extracorporeal membrane oxygenationrelated data of the patients were recorded. Occurrence and stages of renal injury was determined using the revised Acute Kidney Injury Network and Kidney Disease Improving Global Outcomes criteria.
RESULTS: No significant relationship was found between preoperative neutrophil-to-lymphocyte ratio and renal injury (p>0.05). Postoperative neutrophil-to-lymphocyte ratio was higher in patients who developed renal injury, compared to patients without renal injury (8.68 [0.84-42.00] vs. 4.02 [1.04-21.21], respectively, p=0.004). When patients were grouped for renal injury stage according to the revised Acute Kidney Injury Network (p=0.015) and Kidney Disease Improving Global Outcomes (p=0.006) criteria, the patients with more severe renal injury had higher neutrophil-to-lymphocyte ratio. The receiver operating characteristics analysis revealed a cut-off value of 6.71 for the neutrophil-to-lymphocyte ratio for the detection of renal injury. Patients with a value above 6.71 had an odds ratio of 5.941 for occurrence of renal injury.
CONCLUSION: Postoperative, but not preoperative neutrophil-tolymphocyte ratio is associated with presence and severity of renal injury in patients under extracorporeal membrane oxygenation support for postcardiotomy shock. Neutrophil-to-lymphocyte ratio is a simple and inexpensive marker of inflammation in this patient population.
Copyright © 2019, Turkish Society of Cardiovascular Surgery.

Entities:  

Keywords:  Extracorporeal membrane oxygenation; inflammation; neutrophilto- lymphocyte ratio; postcardiotomy shock; renal injury

Year:  2019        PMID: 32082878      PMCID: PMC7021425          DOI: 10.5606/tgkdc.dergisi.2019.17891

Source DB:  PubMed          Journal:  Turk Gogus Kalp Damar Cerrahisi Derg        ISSN: 1301-5680            Impact factor:   0.332


  17 in total

1.  Prognosis of patients with acute respiratory distress syndrome on extracorporeal membrane oxygenation: the impact of urine output on mortality.

Authors:  Ching-Chung Hsiao; Chih-Hsiang Chang; Pei-Chun Fan; Heng-Tsan Ho; Chang-Chyi Jenq; Kuo-Chin Kao; Li-Chung Chiu; Shen-Yang Lee; Hsiang-Hao Hsu; Ya-Chung Tian; Cheng-Chieh Hung; Ji-Tseng Fang; Chih-Wei Yang; Feng-Chun Tsai; Yung-Chang Chen
Journal:  Ann Thorac Surg       Date:  2014-03-28       Impact factor: 4.330

Review 2.  Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis.

Authors:  Chao-Hui Dong; Zhang-Min Wang; Si-Yu Chen
Journal:  Clin Biochem       Date:  2017-11-11       Impact factor: 3.281

3.  Comparison of RIFLE, AKIN, and KDIGO classifications for assessing prognosis of patients on extracorporeal membrane oxygenation.

Authors:  Tsung-Yu Tsai; Hao Chien; Feng-Chun Tsai; Heng-Chih Pan; Huang-Yu Yang; Shen-Yang Lee; Hsiang-Hao Hsu; Ji-Tseng Fang; Chih-Wei Yang; Yung-Chang Chen
Journal:  J Formos Med Assoc       Date:  2017-09-02       Impact factor: 3.282

Review 4.  Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update.

Authors:  Maxwell E Afari; Tariq Bhat
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-03-04

5.  Prognosis of patients on extracorporeal membrane oxygenation: the impact of acute kidney injury on mortality.

Authors:  Yung-Chang Chen; Feng-Chun Tsai; Chih-Hsiang Chang; Chan-Yu Lin; Chang-Chyi Jenq; Kuo-Chang Juan; Hsiang-Hao Hsu; Ming-Yang Chang; Ya-Chung Tian; Cheng-Chieh Hung; Ji-Tseng Fang; Chih-Wei Yang
Journal:  Ann Thorac Surg       Date:  2011-01       Impact factor: 4.330

6.  Neutrophil lymphocyte ratio as a predictor of stroke.

Authors:  Serhat Tokgoz; Mehmet Kayrak; Zehra Akpinar; Abdullah Seyithanoğlu; Figen Güney; Betigül Yürüten
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-03-14       Impact factor: 2.136

Review 7.  The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.

Authors:  Graeme J K Guthrie; Kellie A Charles; Campbell S D Roxburgh; Paul G Horgan; Donald C McMillan; Stephen J Clarke
Journal:  Crit Rev Oncol Hematol       Date:  2013-04-17       Impact factor: 6.312

8.  Risk Factors for Acute Kidney Injury and In-Hospital Mortality in Patients Receiving Extracorporeal Membrane Oxygenation.

Authors:  Sung Woo Lee; Mi-Yeon Yu; Hajeong Lee; Shin Young Ahn; Sejoong Kim; Ho Jun Chin; Ki Young Na
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

9.  The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review.

Authors:  José António Lopes; Sofia Jorge
Journal:  Clin Kidney J       Date:  2012-01-01

Review 10.  The Complex Relationship of Extracorporeal Membrane Oxygenation and Acute Kidney Injury: Causation or Association?

Authors:  Daniel J Kilburn; Kiran Shekar; John F Fraser
Journal:  Biomed Res Int       Date:  2016-02-24       Impact factor: 3.411

View more
  1 in total

1.  The effect of the relationship between post-cardiotomy neutrophil/lymphocyte ratio and platelet counts on early major adverse events after isolated coronary artery bypass grafting.

Authors:  Mustafa Abanoz; Mesut Engin
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-01-13       Impact factor: 0.332

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.